Kellerhals Carrard is well-placed to advise on the full gamut of regulatory, transactional and litigation matters affecting companies within the healthcare and life sciences sector, from clinical trials and regulatory approvals to business operations and M&A. The team is headed up by Claudio Helmle, Jörg von Manger-Koenig and Nicolas Mosimann. Helmle has a particular focus on product approvals and recalls within the pharmaceutical and biotech sectors, while von Manger-Koenig oversees compliance, regulatory and general management issues. Mosimann acts for clients in corporate and IP transactions as well as broader commercial law matters. Other key team members include regulatory expert Thomas Eichenberger and Virginie Rodieux, who oversees licensing agreements, R&D contracts and other IP issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The healthcare and life science team of Kellerhals Carrard provides excellent, timely and thorough legal support.'
- ‘The individuals I work with at this law firm stand out due to their exceptional expertise and knowledge in life sciences, which sets them apart from competitors.'
- 'Partners like Claudio Helmle demonstrate remarkable communication skills and are always responsive, ensuring that client needs are prioritised.'
- 'I have particularly valued their problem-solving ability and personalised attention, as they tailor strategies to meet unique client circumstances.'
- 'They have a thorough knowledge of Swiss healthcare law, know the different authorities and are highly skilled strategists. They form teams if needed and work in a very collaborative and pragmatic way.'
- 'Thomas Eichenberger stands out as the grand seigneur of the Swiss healthcare lawyers. He is a very experienced attorney and a great strategist, providing legal support in a very timely manner and building a great team around him.'
Key clients
- Actelion Pharmaceuticals
- ALK-Abelló
- Baccinex SA
- Bayer
- Biokema
- Cellestia
- Chemspeed Technologies AG
- CSL Behring
- Earlybird Venture Capital
- Eli Lilly
- Entrydell SA
- Fondation EuroVacc
Work highlights
Advised MoonLake Immunotherapeutics on a $500m cross-border debt financing.
Represented CSL Behring in cross-border litigation to safeguard pharmaceutical market access.
Represented ALK-Abelló in regulatory proceedings to secure price increases during a price freeze.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Claudio Helmle; Jörg von Manger-Koenig; Nicolas Mosimann
Other key lawyers
Thomas Eichenberger; Virginie Rodieux